Low prevalence of apolipoprotein E ε4 allele in the neurofibrillary tangle predominant form of senile dementia

Acta Neuropathologica

Volumn 94, Issue 5, 1997, Pages 403-409

  Bancher, C ^a   Egensperger, R ^b   Kosel S ^c   Jellinger, K ^a   Graeber, M B ^d  

^a GENERAL HOSPITAL LINZ   (Austria)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Alzheimer's disease; Amyloid; Apolipoprotein E; Neurofibrillary tangle predominant dementia; Senile plaques

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; DEGENERATIVE DISEASE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRIORITY JOURNAL; SENILE DEMENTIA; SENILE PLAQUE; TEMPORAL LOBE;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; DEMENTIA; DNA; FEMALE; HUMANS; MALE; NEUROFIBRILLARY TANGLES; POLYMERASE CHAIN REACTION; SENILE PLAQUES; TEMPORAL LOBE;

EID: 0030831549     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010050726     Document Type: Article

References (75)

1. Asada T, Kariya T, Yamagata Z, Kinoshita T, Asaka A (1996) Apolipoprotein E allele in centenarians. Neurology 46: 1484
2. Bancher C, Jellinger KA (1994) Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: a rare subtype in very old subjects. Acta Neuropathol 88: 565-570
3. Bancher C, Jellinger K, Lassmann H, Fischer P, Leblhuber F (1996) Correlations between mental state and quantitative neuropathology in the Vienna Prospective Longitudinal Study on Dementia. Eur Arch Psychiatry Clin Neurosci 246: 137-146
4. Bancher C, Leitner H, Jellinger K, Eder H, Setinek U, Fischer P, Wegiel J, Wisniewski HM (1996) On the relationship between measles virus and Alzheimer neurofibrillary tangles in sub-acute sclerosing panencephalitis. Neurobiol Aging 17: 527-533
5. Benjamin R, Leake A, Ince PG, Perry RH, McKeith IG, Edwardson JA, Morris CM (1995) Effects of apolipoprotein E genotype on cortical neuropathology in senile dementia of the Lewy body and Alzheimer's disease. Neurodegeneration 4: 443-448
6. Bierer LM, Hof PR, Purohit DP, Carlin L, Schmeidler J, Davis KL, Perl DP (1995) Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch Neurol 52: 81-88
7. Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82: 239-259
8. Brousseau T, Legrain S, Berr C, Gourlet V, Vidal O, Amouyel P (1994) Confirmation of the ε4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease. Neurology 44: 342-344
9. Cariolou MA, Kokkofitou A, Manoli P, Christou S, Karagrigoriou A, Middleton L (1995) Underexpression of the apolipoprotein E2 and E4 alleles in the Greek Cypriot population of Cyprus. Genet Epidemiol 12: 489-497
10. Castano EM, Prelli F, Wisniewski T, Golabek A, Kumar RA, Soto C, Frangione B (1995) Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. J Biochem 306: 599-604
11. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923
12. Corder EH, Basun H, Lannfelt L, Viitanen M, Winblad B, Korten AE, Mackinnon AJ, Henderson AS, Easteal S, Jorm AF (1996) Attenuation of apolipoprotein E ε4 allele gene dose in old age. Lancet 347: 542
13. Corder EH, Lannfelt L, Viitanen M, Corder LS, Manton KG, Winblad B, Basun H (1996) Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition. Arch Neurol 53: 418-422
14. Corey-Bloom J, Sabbagh MM, Hansen LA, Masliah E, Salmon D, Hohl U, Thal LJ (1997) 'Plaque-only' Alzheimer's disease: a clinical and pathologic examination. Neurology 48: A103
15. Davignon J, Gregg RE, Sing CF (1988) Apolipoportein E polymorphism and atherosclerosis. Arteriosclerosis 8: 1-21
16. Dickson DW, Davies P, Bevona C, Hoeven KH van, Factor SM, Grober E, Aronson MK, Crystal HA (1994) Hippocampal sclerosis: a common pathological feature of dementia in very old (80 years of age) humans. Acta Neuropathol 88: 212-221
17. Egensperger R, Kösel S, Schnabel R, Mehraein P, Graeber MB (1995) Apolipoprotein E genotype and neuropathological phenotype in two members of a German family with chromosome 14-linked early onset Alzheimer's disease. Acta Neuropathol 90:257-265
18. Egensperger R, Bancher C, Kösel S, Jellinger K, Mehraein P, Graeber MB (1996) The apolipoprotein E ε4 allele in Parkinson's disease with Alzheimer lesions. Biochem Biophys Res Commun 224: 484-486
19. Geddes JF, Vowles GH, Robinson SFD, Sutcliffe JC (1996) Neurofibrillary tangles, but not Alzheimer-type pathology, in a young boxer. Neuropathol Appl Neurobiol 22: 12-16
20. Ghetti B, Murrell J, Farlow MR, Crowther RA, Goedert M, Spillantini MG (1997) Molecular neuropathology of a multiple system tauopathy: a chromosome 17 linked presenile dementia. Neurology 48: A356
21. Gomez-Isla T, West HL, Rebeck GW, Harr SD, Growdon JH, Locascio JJ, Perls TT, Lipsitz LA, Hyman BT (1996) Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease. Ann Neurol 39: 62-70
22. Hansen LA, Galasko D, Samuel W, Xia Y, Chen X, Saitoh T (1994) Apolipoprotein E ε4 is associated with increased neurofibrillary pathology in the Lewy body variant of Alzheimer's disease. Neurosci Lett 182: 63-65
23. Harrington CR, Louwagie J, Rossau R, Vanmechelen E, Perry RH, Perry EK, Xuereb JH, Roth M, Wischik CM (1994) Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. Am J Pathol 145: 1472-1484
24. Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I (1994) Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44: 2015-2019
25. Hendrie HC, Osuntokun BO, Hall KS, Ogunniyi AO, Hui SL, Unverzagt FW, Gureje O, Rodenberg CA, Baiyewu O, Musick BS, Adeyinka A, Farlow MR, Oluwole SO, Class CA, Komolafe O, Brashear A, Burdine V (1995) Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. Am J Psychiatry 152: 1485-1492
26. Hyman BT, West HL, Rebeck GW, Buldyrev V, Mantegna RN, Ukleja M, Havlin S, Stanley HE (1995) Quantitative analysis of senile plaques in Alzheimer disease: observation of log normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). Proc Natl Acad Sci USA 92: 3586-3590
27. Ikeda K, Akiyama H, Arai T, Mori H, Sahara N, Sakata M, Mizutani T (1996) Senile dementia with abundant neurofibrillary tangles without accompanying senile plaques. A new disease entity separable from SDAT? Neurobiol Aging Suppl 17: S150-S151
28. Ikeda K, Akiyama H, Arai T, Sahara N, Mon H, Usami M, Sakata M, Mizutani T, Wakabayashi K, Takahashi H (1997) A subset of senile dementia with high incidence of the ApoE ε2 allele. Ann Neurol 41: 693-695
29. Ikeda K, Akiyama H, Sahara N, Mori H, Usami M, Sakata M, Mizutani T, Wakabayashi K, Takahashi H (1997) Senile dementia with abundant neurofibrillary tangles without accompanying senile plaques: a subset of senile dementia with high incidence of the ApoE ε2 allele. In: Iqbal K, Winblad B, Nishimura T, Takeda M, Wisniewski HM (eds) Alzheimer's disease: biology, diagnosis and therapeutics. Wiley, Sussex, pp 257-265
30. Jellinger KA (1994) Hippocampal sclerosis: a common pathological feature of dementia in very old humans [Editorial]. Acta Neuropathol 88: 599
31. Khachaturian ZS (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42: 1097-1105
32. Köstel S, Graeber MB (1994) Use of neuropathological tissue for molecular genetic studies: parameters affecting DNA extraction and polymerase chain reaction. Acta Neuropathol 88: 19-25
33. LaDu MJ, Lukens JR, Reardon CA, Getz OS (1997) Association of human, rat, and rabbit apolipoprotein E with β-amyloid. J Neurosci Res 49: 9-18
34. Landen M, Thorsell A, Wallin A, Blennow K (1996) The apolipoprotein E allele ε4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease. J Neurol Neurosurg Psychiatry 61: 352-356
35. Lippa CF, Saunders AM, Smith TW, Swearer JM, Drachman DA, Ghetti B, Nee L, Pulaski-Salo D, Dickson D, Robitaille Y, Bergeron C, Grain B, Benson MD, Farlow M, Hyman BT, St. George-Hyslop P, Roses AD, Pollen DA (1996) Familial and sporadic Alzheimer's disease: neuropathology cannot exclude a final common pathway. Neurology 46: 406-412
36. Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, McKee A, Dickson D, Bancher C, Tabaton M, Jellinger K, Anderson DW (1996) Validity and reliability of the preliminary NINDS neuropathological criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 55: 97-105
37. Ma J, Yee A, Brewer BH Jr, Das S, Potter H (1994) Amyloid-associated protein a1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372: 92-94
38. Maestre G, Ottman R, Stern Y, Gurland B, Chun M, Tang MX, Shelanski M, Tycko B, Mayeux R (1995) Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risk. Ann Neurol 37: 254-259
39. Mann DMA, Pickering Brown SM, Siddons MA, Iwatsubo T, Ihara Y, Asami-Odaka A, Suzuki N (1995) The extent of amyloid deposition in brain in patients with Down's syndrome does not depend upon the apolipoprotein E genotype. Neurosci Lett 96:105-108
40. Martins RN, Clarnette R, Fisher C, Broe GA, Brooks WS, Montgomery P, Gandy SE (1995) ApoE genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome. NeuroReport 6: 1513-1516
41. Marz W, Scharnagl H, Kirca M, Bohl J, Gross W, Ohm TG (1996) Apolipoprotein E polymorphism is associated with both senile plaque load and Alzheimer type neurofibrillary tangle formation. Ann N Y Acad Sci 777: 276-280
42. McKhann CD, Drachman DA, Folstein MF, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944
43. Mirra SS, Hart MN, Terry RD (1993) Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. Arch Pathol Lab Med 17: 132-144
44. Morris CM, Benjamin R, Leake A, McArthur FK, Candy JM, Ince PC, Torvik A, Bjertness E, Edwardson JA (1995) Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians. Neurosci Lett 201: 45-48
45. Nagy ZS, Esiri MM, Jobst KA, Johnston C, Litchfield S, Sim E, Smith AD (1995) Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience 69: 757-761
46. Nalbantoglu J, Gilfix BM, Bertrand P, Robitaille Y, Gauthier S, Rosenblatt DS, Poirier J (1994) Predictive value of apolipoprotein E genotyping in Alzheimer's disease; results of an autopsy series and an analysis of several combined studies. Ann Neurol 36: 889-895
47. Ohm TG, Kirca M, Bohl J, Schamagl H, Gross W, Marz W (1995) Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer type neurofibrillary tangle formation. Neuroscience 66: 583-587
48. Olichney JM, Hansen LA, Galasko D, Saitoh T, Hofstetter CR, Katzman R, Thal LJ (1996) The apolipoprotein E ε4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 47: 190-196
49. Pirtillä T, Soininen H, Mehta PD, Heinonen O, Lehtimäki T, Bogdanovic N, Paljärvi L, Kim KS, Kosunen B, Winblad B, Riekkinen P Sr, Wisniewski HM (1997) Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains. Neurobiol Aging 18: 121-127
50. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342: 697-699
51. Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, Niinistö L, Halonen P, Kontula K (1995) Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. N Engl J Med 333: 1242-1247
52. Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11: 575-580
53. Rebeck GW, Perls TT, West HL, Sodhi P, Lipsitz LA, Hyman BT (1994) Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology 44: 1513-1516
54. Saunders AM, Strittmatter WJ, Schmechel D, St. George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-McLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD (1993) Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472
55. Schächter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L, Cohen D (1994) Genetic associations with human longevity at the APOE and ACE loci. Nature Genet 6: 29-32
56. Schmechel DE, Saunders AM, Strittmatter WJ, Grain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD (1993) Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 90: 9649-9653
57. Schmidt K, Lyons KE, Hubble JP, Schellenberg G, Golbe LI, Lang AE, Galvez Jimenez N, Hershey L, Koller WC, Anouti A (1996) Normal distribution of apolipoprotein E alleles in progressive supranuclear palsy. Neurology 46: 1156-1157
58. Sima AAF, Defendini R, Keohane C, D'Amato C, Foster NL, Parchi P, Gambetti P, Lynch T, Wilhelmsen KC (1996) The neuropathology of chromosome 17-linked dementia. Neurology 39: 734-743
59. Sobel E, Louhija J, Sulkava R, Davanipour Z, Kontula K, Miettinen H, Tikkanen M, Kainulainen K, Tilvis R (1995) Lack of association of apolipoprotein E allele epsilon 4 with late-onset Alzheimer's disease among Finnish centenarians. Neurology 45: 903-907
60. Soto C, Golabek A, Wisniewski T, Castano EM (1996) Alzheimer's β-amyloid peptide is conformationally modified by apolipoprotein E in vitro. NeuroReport 7: 721-725
61. Sparks DL, Scheff SW, Liu H, Landers T, Danner F, Coyne CM, Hunsaker JC III (1996) Increased density of senile plaques (SP), but not neurofibrillary tangles (NFT), in non-demented individuals with the apolipoprotein E4 allele: comparison to confirmed Alzheimer's disease patients. J Neurol Sci 138:97-104
62. Spillantini MG, Crowther RA, Goedert M (1996) Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles. Acta Neuropathol 92: 42-48
63. Strittmatter WJ, Roses AD (1996) Apolipoprotein E and Alzheimer's disease. Annu Rev Neurosci 19: 53-77
64. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance MA, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 90: 1977-1981
65. Sumi SM, Bird TD, Nochlin D, Raskind MA (1992) Familial presenile dementia with psychosis associated with cortical neurofibrillary tangles and degeneration of the amygdala. Neurology 42: 120-127
66. Tabaton M, Rolled M, Masturzo P, Cammarata S, Angelini G, Hansen LA, Saitoh T, Petersen RB, Perry G, Richey P, Gambetti P, Bertolini S (1995) Apolipoprotein E epsilon 4 allele frequency is not increased in progressive supranuclear palsy. Neurology 45: 1764-1765
67. Tang MX, Maestre G, Tsai WY, Liu XH, Feng L, Chung WY, Chun M, Schofield P, Stern Y, Tycko B, Mayeux R (1996) Relative risk of Alzheimer disease and age at onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. Am J Hum Genet 58: 574-584
68. Terry RD, Hansen LA, DeTeresa R, Davies P, Tobias H, Katzman R (1987) Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles. J Neuropathol Exp Neurol 46: 262-268
69. Tierney MC, Fisher RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Nieuwstraten P (1988) The NINCDS ADRDA Work Group criteria for the clinical diagnosis of possible Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 38: 359-364
70. Ulrich J, Spillantini MG, Goedert M, Dukas L, Stähelin HB (1992) Abundant neurofibrillary tangles without senile plaques in a subset of patients with senile dementia. Neurodegeneration 1: 257-284
71. Van Broeckhoven C, Backhovens H, Cruts M, Martin JJ, Crook R, Houlden H, Hardy J (1994) ApoE genotype does not modulate age of onset in famlilies with chromosome 14 encoded Alzheimer's disease. Neurosci Lett 169: 179-180
72. Wisniewski HM, Wegiel J, Kotula L (1996) Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines. Neuropathol Appl Neurobiol 22: 3-11
73. Wisniewski K, Jervis GA, Moretz RC, Wisniewski HM (1979) Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia. Ann Neurol 5: 288-294
74. Yamada M, Itoh Y, Suematsu N, Otomo E, Matsushita M (1996) Apolipoprotein E genotype in elderly nondemented subjects without senile changes in the brain. Ann Neurol 40: 243-245
75. Zubenko GS, Stiffler S, Stabler S, Kopp U, Hughes HB, Cohen BM, Moossy J (1994) Association of the apolipoprotein ε4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease. Am J Med Genet 54: 399-205